FDA-Drug2021-11-24Class III
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications
Sold states
Nationwide and Puerto Rico
Affected count
64,978 patches
Manufactured in
400 Interpace Pkwy, N/A, Parsippany, NJ, United States
Products
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0235-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief